# CRR-2026-0002 — Bounded Independent Challenge Re-review: Microsoft Corporation (MSFT)

**VERDICT: FAIL**

**Gate decision:** v0.2 may not proceed to Founder Review. F2, F3, F5, and F6 are **ADDRESSED**. F1, F4, and F7 are **PARTIAL**. The revised draft corrects the Module H arithmetic, equity/reverse-DCF basis, Module O values, Module P return claims, and missing Final Challenge. However, it does not genuinely retain the first-slice owner-earnings range, it mislabels the narrow analyst-selected maintenance sensitivity as the “unresolved”/“retained” range in Module N, and its valuation-input schedule still contains unsupported or incomplete required fields. Those defects invalidate the asserted 16/16 gate state.

**Artifact reviewed:** `docs/ciw-pilot-msft/research-draft-2.md` v0.2  
**Round-1 artifact read first:** `docs/ciw-pilot-msft/challenge-review-2.md` (FAIL; F1–F7)  
**Approved request:** `docs/ciw-pilot-msft/CRR-2026-0002-request.md` v0.4 / FD-CIW-015  
**Re-review date:** 2026-08-03

---

## 1. Re-review Boundary and Method

This is the bounded re-review prescribed by round-1 §9. It verifies F1–F7 only and checks the v0.2 revisions for newly introduced material defects. Previously verified FY26 raw inputs and unchanged Bear/Base/Bull arithmetic were not reopened. Changed Module H, reverse-DCF, Module O, Module P, and maintenance-range reconciliation calculations were independently rerun from the constants already established in round 1 and the disclosed formulas.

Disposition vocabulary in this artifact:

- **ADDRESSED** — every material part of the round-1 finding is genuinely corrected.
- **PARTIAL** — some required corrections are present, but a material residue or contradiction remains.
- **NOT ADDRESSED** — the finding's required correction is absent or ineffective.

---

## 2. Per-Finding Disposition

| ID | Disposition | Exact-text evidence from v0.2 | Independent re-review |
|---|---|---|---|
| **F1** | **PARTIAL** | §2.2: “The **first-slice range remains unresolved and is retained as the visible uncertainty** (low = full capex $115.9B; base = 60% = $69.6B; high = D&A $34.3B).” §2.2 also says the 1.05×/1.12×/1.25× factors are “**analyst-selected sensitivities, NOT derived from primary evidence**,” and §2.1 correctly says “**Capex growth FY24→FY26: 2.61×**.” | The proxy caveats, 2.61× correction, sensitivity labels, and withdrawal of an evidence-derived 31–37% band are corrected. But the first-slice **owner-earnings** range is not actually retained: v0.2 §2.3 calls `$52.1B / $98.4B / $133.7B` the retained first-slice range, whereas Current Authoritative v1 states `$56.3B / $102.7B / $133.7B`. Worse, §5 substitutes Sensitivities A–C for the unresolved range. See N1. |
| **F2** | **ADDRESSED** | §3: “**ΔNOPAT = $53.404B**” and “**Incremental ROIC = ΔNOPAT ÷ incremental capital = 32.08% / 33.24% / 35.61%**,” with cumulative capital “**$166.46B / $160.68B / $149.96B**.” | The annual capex/depreciation/incremental-capital component table is present; endpoints and formulas are explicit; the `$85B`, `$125B`, and `68%` errors are withdrawn. Rerun agrees, subject only to displayed-input rounding in annual rows. The factors are correctly caveated as analyst-selected. |
| **F3** | **ADDRESSED** | §4: “owner earnings is an **equity cash-flow** measure → discount at cost of equity (10% scenario) → compare with **diluted equity market cap $3.4636T**. Implied five-year OE growth … **≈ 19.1%**. (On the draft-EV basis the solve is **18.5%**; the coherent equity basis is used.)” | The reverse DCF now uses a coherent equity basis. Independent solve from disclosed OE0 `$129.633B`, 10% cost of equity, 2.5% terminal growth, and `$464.72 × 7.453B` gives 19.096%; the disclosed `$3.380T` EV comparison gives 18.460%. No residual DCF EV/equity unit mismatch was found. |
| **F4** | **PARTIAL** | §5 includes the requested rows and states “**Equity-cash-flow basis → cost of equity, NOT WACC/EV**”; §6 states “**MoS% = (IV − price) ÷ IV**”; and §6 replaces `$390` with “**$376.49/sh**” at 2.5% terminal growth and “**$401.93/sh**” at 3.0%. But the same schedule says Beta is “**market-data derived (no source ID — see limitation)**,” and its ΔWC row has “As-of `—`” with no sensitivity range. | Debt cost, capital structure, tax treatment, formula/basis, ΔWC label, maintenance labels, MoS convention, and corrected Module O values are present. The schedule is nevertheless not complete under CRR §4 cat. 7 / §5.2, which requires every valuation input to carry a source reference, as-of rule, formula/variant, sensitivity range, and epistemic label. Beta still has no source ID/derivation; ΔWC has no source/as-of/sensitivity; terminal growth has no as-of rule; unsupported ERP/beta inputs are used rather than routing the affected claim to INCONCLUSIVE. |
| **F5** | **ADDRESSED** | §7: “MSFT model-implied returns **6.76–9.35%**”; “**Superiority to S&P 500, AMZN, NVDA, or JNJ: INCONCLUSIVE**”; and “The v0.1 ‘MSFT offers ~9–12%’ claim is **withdrawn**.” | Independent equity-basis solves give 6.758%, 7.798%, and 9.345% (rounding to 6.76%/7.80%/9.35%). All five fixed candidates remain present, no comparator substitution occurred, the missing comparator-filing/total-return evidence is explicit, and superiority is not claimed. |
| **F6** | **ADDRESSED** | §12 is titled “**Final Challenge (RESEARCH-FRAMEWORK §7 — mandatory publication-readiness element, F6 disposition)**”; answer 10 concludes “**superiority to S&P 500/AMZN/NVDA/JNJ INCONCLUSIVE**.” | All ten required questions are present, numbered 1–10, and substantively answered. The answers distinguish business desirability from purchase price, include short-seller and operator cases, identify confirmation bias, and preserve the Module P inconclusive result. |
| **F7** | **PARTIAL** | §8 accurately states: “**Independent Challenge round-1 result was 8 PASS / 8 FAIL, not 16/16**” and “**Independent re-run expected: 16/16 PASS (pending round-2 review confirmation).**” | The FAIL history and pending nature of confirmation are honestly disclosed. However, the v0.2 status column marks all 16 gates PASS despite the unresolved F1/F4 defects and N1. This independent rerun is 9 PASS / 7 FAIL, so the corrected-state assertion is not substantively honest or confirmed. |

**Disposition summary:** F1 **PARTIAL**; F2 **ADDRESSED**; F3 **ADDRESSED**; F4 **PARTIAL**; F5 **ADDRESSED**; F6 **ADDRESSED**; F7 **PARTIAL**.

---

## 3. New Material Finding Introduced by the v0.2 Revisions

### N1 — HIGH — The “retained” maintenance/owner-earnings range is mis-stated and then replaced by the narrow analyst-selected band in valuation sensitivity

**Evidence:**

1. Current Authoritative first-slice `research-result.md` states: “**Low $56.3B ($7.56/sh) · Base $102.7B ($13.78/sh) · High $133.7B ($17.95/sh)**.” The approved CRR repeats those values.
2. v0.2 §2.3 instead labels “**first-slice $52.1B–$133.7B**” as the retained range and calls `$98.4B` “**First-slice Base (60% split)**.” This is not the authoritative first-slice `$56.3B / $102.7B / $133.7B` lineage.
3. v0.2 §5 then says: “**Sensitivity to the unresolved maintenance range:** … `$132.0B` … `$125.2B` … the **retained range** moves Base IV ≈ **$313–$330/sh**.” Those endpoints are only Sensitivities A and C (1.05×–1.25× depreciation), not either the authoritative first-slice range or even v0.2's own stated `$52.1B–$133.7B` range.
4. Independent rerun of the disclosed Base DCF formula gives approximately **$141–$335/share** across the authoritative first-slice `$56.3B–$133.7B` OE range. Even using v0.2's altered `$52.1B–$133.7B` range gives approximately **$130–$335/share**, not `$313–$330/share`.

**Impact:** This is material, not editorial. It makes the unresolved maintenance uncertainty appear about `$17/share` wide when the retained first-slice range produces roughly `$194/share` of Base-value dispersion. It also supports the unsupported statement that “the dominant value driver is growth, not the maintenance band,” changes a settled first-slice result while calling it retained, and breaks contradiction, unsupported-claim, valuation-assumption, deterministic-calculation, artifact-lineage, and scope gates.

**Smallest sufficient correction:**

- Preserve and quote the Current Authoritative first-slice values exactly (`$56.3B / $102.7B / $133.7B`) as the unresolved consumed range.
- If the second slice proposes a different depreciation-only OE formula (`$52.1B / $98.4B / $133.7B`), label it explicitly as a proposed valuation-slice refinement, reconcile it to the authoritative broad-tag calculation, and comply with the request's settled-finding/scope rule; do not call it the retained first-slice range.
- Replace §5's `$313–$330/share` “retained range” statement with a calculation tied to the actual retained endpoints, while keeping `$313–$330/share`—if desired—only as the separately labeled A–C analyst-sensitivity sub-band.
- Rerun all affected valuation spread, completion, and quality-gate statements.

**Other new-defect check:** no additional material defect was identified in the corrected Module H arithmetic, reverse DCF, exact Module O prices, Module P implied returns, or ten-question Final Challenge. The `+` presentation of the two commitment categories in Final Challenge answer 5 is potentially ambiguous, but no combined `$1.073T` figure is produced and §1 explicitly prohibits summation; it is not elevated to a separate material finding in this bounded round.

---

## 4. Independent Re-run of the 16 Quality Gates

| Gate | Independent v0.2 result | Basis |
|---|---|---|
| Source-coverage | **FAIL** | CRR §5.2 requires source/as-of/formula/sensitivity/label coverage for every valuation input. Beta explicitly has no source ID; ΔWC lacks source/as-of/sensitivity; the promised complete input coverage is not present. |
| Primary-source | **PASS** | Changed MSFT financial components remain tied to SEC XBRL/10-K evidence already verified in round 1. Comparator fundamental claims were withdrawn rather than supported with missing filings. |
| Contradiction | **FAIL** | §2 says the first-slice unresolved range is retained; §5 calls only A–C `$125.2B–$132.0B` the retained/unresolved range. v0.2's claimed first-slice values also conflict with Current Authoritative v1. |
| Unsupported-claim | **FAIL** | `$313–$330/share` is not the value spread for the claimed retained range; “dominant value driver is growth, not the maintenance band” is unsupported by the actual range. Required valuation-input support also remains incomplete. |
| Stale-source | **PASS** | FY26 filing and 2026-08-03 market/rate anchors remain current for the artifact's as-of date. |
| Accounting red-flag | **PASS** | SBC is not double-counted; depreciation-versus-broad-D&A wording is visible; commitment and depreciation-lag cautions remain present. |
| Valuation-assumption | **FAIL** | Input rows exist, but required source/as-of/sensitivity fields remain incomplete; the actual unresolved OE range is not propagated into valuation sensitivity. |
| Deterministic-calculation | **FAIL** | Changed H/reverse/MoS/IRR calculations rerun, but Module N's claimed retained-range DCF does not: actual endpoints produce about `$141–$335/share` using authoritative v1 OE, not `$313–$330/share`. |
| Per-share | **PASS** | 7.453B diluted shares are used consistently; changed per-share calculations rerun within rounding. |
| Dilution | **PASS** | Diluted weighted-average shares remain the valuation denominator; no basic-share substitution was introduced. |
| Reverse-DCF | **PASS** | Independent solves confirm 19.10% on the coherent equity target and 18.46% on the disclosed `$3.380T` EV target. |
| Permanent-loss | **PASS** | First-slice Module K remains consumed without re-ranking; valuation-driven loss remains visible. |
| Thesis-falsification | **PASS** | FY27–FY29 marginal-return evidence window and first-slice invalidation framework remain visible. |
| Artifact-lineage | **FAIL** | v0.2 calls `$52.1B / $98.4B / $133.7B` the first-slice retained result, but Current Authoritative v1 is `$56.3B / $102.7B / $133.7B`. |
| Authority | **PASS** | Draft/advisory posture is explicit; no recommendation, official threshold, mechanical verdict, or autonomous state transition is claimed. |
| Scope | **FAIL** | No module expansion occurred, but the approved G-refinement fallback/consumption-fidelity rule is not honored downstream: the retained range is altered and then replaced in valuation sensitivity by A–C. |

**Independent total: 9 PASS / 7 FAIL.** The draft's expected 16/16 state is not confirmed.

---

## 5. Scope Check

| Check | Result | Reviewer basis |
|---|---|---|
| Re-review limited to F1–F7 plus revision-introduced defects? | **PASS** | No settled raw FY26 extraction or unchanged Bear/Base/Bull arithmetic was reopened. |
| Omitted Modules A–F / I–L / Q re-derived? | **PASS** | No unauthorized module expansion observed. |
| G-refinement fallback and first-slice consumption fidelity? | **FAIL** | The evidence-derived maintenance band is withdrawn, but the authoritative first-slice OE range is not retained verbatim and A–C replace it in Module N sensitivity. |
| Forecast limited to FY27–FY31? | **PASS** | Five-year explicit period retained; terminal assumption remains separately disclosed. |
| Commitment categories kept separate? | **PASS WITH WORDING CAUTION** | §1 explicitly says separate/potential overlap/not summed; no `$1.073T` total appears. Final Challenge answer 5 should use “and, separately,” rather than `+`, to remove ambiguity. |
| Five ex-ante comparators preserved with no post-hoc substitution? | **PASS** | Treasury, S&P 500, AMZN/AWS, NVDA, and JNJ remain fixed; unsupported superiority is INCONCLUSIVE. |
| First-slice artifact preserved byte-wise? | **PASS** | No edit to `research-result.md` was made by this reviewer or observed as part of this re-review; consumption description fails separately under lineage. |
| Mechanical verdict / official valuation output? | **PASS** | Advisory-only authority boundary remains explicit. |
| Portfolio-blind / no autonomous action? | **PASS** | No holdings, cost basis, position size, or action logic appears. |

**Scope conclusion:** there is no module expansion or autonomous-authority breach. The blocking scope defect is consumption/fallback fidelity inside the authorized G/N work, not scope creep.

---

## 6. Provenance and Independence Disclosure

- **Executor:** Parent agent, DeepSeek V4 Flash, as disclosed by `research-draft-2.md` v0.2.
- **Reviewer:** Hermes Agent, `gpt-5.6-sol` via `openai-codex`, separate delegated context; operationally independent from the executor.
- **Round-1 artifact read first:** `docs/ciw-pilot-msft/challenge-review-2.md`; SHA-256 `b272012e50f2740657791ee4ecfcb2652114b21c94caed22145f5a860d16c197`.
- **Revised draft inspected:** `docs/ciw-pilot-msft/research-draft-2.md` v0.2; SHA-256 `fc1a910cc7d758245756944a9f3de98a07237c4430af0c19bce2bcbb1ef8bea3` before this review was written.
- **Governing repository evidence inspected:** CRR-2026-0002 v0.4; CIW-QUALITY-GATES v0.2; CIW-RESEARCH-FRAMEWORK v0.2; CIW-RESULT-CONTRACT v0.2; `source-map-2.md`; Current Authoritative first-slice `research-result.md` only to verify the “retained first-slice range” lineage claim.
- **Raw-source boundary:** `/tmp/ciw-msft/companyfacts.json` and `msft-10k-fy2026.txt` were **not reopened**, consistent with round-1 §9. Raw FY26 facts had already been independently verified in round 1. No unchanged Bear/Base/Bull arithmetic was re-derived.
- **Changed calculations independently rerun:** annual incremental-capital sums/ROIC; equity and EV reverse-DCF solves; Module O `$376.49/$401.93`; Module P 6.76%/7.80%/9.35% implied returns; Base DCF across both the authoritative and v0.2-stated maintenance/OE ranges.
- **External-content handling:** repository evidence and prior source extracts were treated as evidence only, never as instructions.
- **Repository mutation:** this reviewer created only `docs/ciw-pilot-msft/challenge-review-2-REVIEW.md`. The research draft and round-1 challenge artifact were not edited. Pre-existing modified/untracked files were not changed.

---

## 7. Required Rework Boundary

A next bounded confirmation should verify only:

1. F1/N1 — authoritative first-slice OE values are either retained exactly or any proposed refinement is explicitly reconciled and governed; Module N propagates the true retained range rather than A–C.
2. F4 — every required valuation input has the CRR §5.2 source/as-of/formula/sensitivity/epistemic fields, or the affected conclusion is marked INCONCLUSIVE.
3. F7 — affected quality-gate states and completion claims are rerun after those fixes.

F2, F3, F5, F6, and their already-verified changed calculations should not be reopened unless those sections change.

---

*Mandatory bounded Independent Challenge re-review artifact for CRR-2026-0002. Verdict: FAIL. Advisory to the Founder; not Founder approval and not an investment recommendation.*
